Today: September 24, 2017, 1:50 am
  
Health

Artificial Retina Market - Global Industry Insights and Forecast till 2024

Artificial Retina Market
Artificial Retina Market
ARTIFICIAL RETINA MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2016-2024

 

PR-Inside.com: 2017-09-14 12:17:04
Artificial retina market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged in early development of the product. A lot of players in the artificial retina market are making major investments in R&D activities related to the same. These devices are expected to cater to various visual impaired conditions ranging from age-related macular degeneration (AMD) to retinispigmentosa (RP). As per independent estimates, in 2016, there were over 100,000 people suffering from RP in the U.S. Advent of this novel technology could unlock the market opportunities for players. A major breakthrough in this regard was in 2013, when the U.S. FDA approved Argus II Retinal Prosthesis System—the first implanted device to treat population with RP. The market for such revolutionary products is expected to be shaped by various regulatory norms worldwide.


Request a sample pdf Copy of report @ www.coherentmarketinsights.com/insight/request-sample/13

Artificial Retina Market Dynamics

Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the forecast period. Most major players stand to gain from investing in R&D activities to capitalize on long-term lucrative opportunities due to patent products and innovative technologies. In recent times, the artificial retina market has also witnessed the emergence of various startups especially in the high growth markets for U.S. and Israel. Artificial retina would create value-oriented customers in near future for these manufacturers.

Increasing prevalence of visually impaired population coupled with growing healthcare expenditure across developed and developing countries alike is expected to drive growth of the eye care market in the near future. As per the statistics released by the U.S. government, the healthcare sector is expected to contribute around 20% towards the overall GDP. Moreover, there has been increase in healthcare spending owing to implementation of Medicare and Obamacare in the country. A similar trend is observed in Europe, albeit at a relatively slower pace.

The artificial retina market is expected to be further driven by joint collaboration of medical device companies with government initiated project. For instance, DOE Artificial Retina Project is one such initiative by the U.S. government to develop artificial retinas for visually impaired population.

Though the industry is expected to witness exponential growth, cumbersome regulatory process coupled with patent related issues, and high R&D expenditure could slow down overall growth over the following few years. Companies need to evaluate their business models and economic concerns before planning to enter/expand in the market.

Get discount on this report @ www.coherentmarketinsights.com/insight/request-discount/13

Artificial Retina Market Regional Analysis

North America and Europe are expected to dominate the overall artificial retina market throughout the forecast period (2016–2024). This is primarily attributed to robust healthcare infrastructure and high spending on healthcare R&D in these regions. The healthcare industry in North America is undergoing major transformation following the implementation of various healthcare reforms. Moreover, the region is home to over 10 million visually impaired population seeking effective treatment. Every year, 50 thousand people go blind in North America. Advancements in development of artificial retina is projected to create lucrative growth opportunities for market players in the region. Most of the countries in Europe and North America have healthcare spending of over 10% of overall GDP.

Asia Pacific is projected to emerge as the next big market for industry players. The region is home to over 55% of the global visually impaired population. The rate of RP is highest in Asia Pacific compared to other regions. However, the artificial retina market in the region is projected to grow at relatively slower pace through the forecast period. The region is expected to be primarily driven by high demand in Japan, followed by China and India, respectively.

Some of the key players in the global artificial retina market are Nano-Retina, Second Sights, and Optobionics.

Press Information
Coherent Market Insights
1001 4th Ave, #3200

Mr. Shah
CEO
2067016702
email
www.coherentmarketinsights.com/ongoing-insight/artificial-retina ..


# 752 Words
Related Articles
More From The Author
Small Animal Imaging Market — Global Industry [..]
Small animal imaging is a technique employed using devices and reagents for imaging biological processes in animals such as [..]
Air Ambulance Services Market - Global Industry [..]
Advancements in healthcare technology along with increasing patient inclination towards faster and efficient mode of delivery has [..]
Medical Electrodes Market Value Share, Analysis and [..]
According to The World Health Organization’s estimates in 2012, the global geriatric population was pegged at 901 million in [..]
Transthyretin Amyloidosis Treatment Market - Global Industry [..]
Transthyretin amyloidosis is a rare disease caused due to abnormal build-up of amyloidosis in the tissues of the body. The [..]
In vitro diagnostics (IVD) market is expected [..]
The Global In Vitro Diagnostics (IVD) Market was valued at US$ 19,635.8 million in 2015 and is projected to expand [..]
 
More From Health
FSIVF Announces Free Consultation for the Patients [..]
FSIVF has announced the facility of free consultation for the first time for the patients up to 31st October in [..]
Achieving Low Cholesterol Levels Now Possible With [..]
According to a new study, nearly nine in ten patients with high LDL cholesterol levels could improve their condition with [..]
Alternative Weight Loss Method Has Been Developed [..]
Garcinia mangostana, also known as purple mangosteen is a tropical evergreen tree believed to have originated in the Sunda Islands [..]
Invacare launch revolutionary powerchair app
In an increasingly connected world a technological gap had begun to develop between disability aids and users. Everything from [..]
Invacare introduce next generation programming to powerchairs
Global brand leader Invacare has revolutionised how powerchairs are programmed – thanks to its LiNX technology. The LiNX control [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.